| DKK1 — Dickkopf WNT Signaling Pathway Inhibitor 1 | |
|---|---|
| Symbol | DKK1 |
| Full Name | Dickkopf WNT Signaling Pathway Inhibitor 1 |
| Chromosome | 10q21.1 |
| NCBI Gene | 2698 |
| Ensembl | ENSG00000107957 |
| OMIM | 605386 |
| UniProt | O94907 |
| Diseases | Alzheimer's Disease, Parkinson's Disease, Bone Disorders |
| Expression | Brain (low), Bone, Kidney, Liver |
Dkk1 — Dickkopf Wnt Signaling Pathway Inhibitor 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DKK1 (Dickkopf WNT Signaling Pathway Inhibitor 1) is a gene that encodes a secreted protein which acts as a potent inhibitor of the canonical Wnt/β-catenin signaling pathway. DKK1 is best known for its role in embryonic development and bone homeostasis, but increasingly recognized as an important regulator in neurodegenerative diseases.
DKK1 is a member of the dickkopf family of proteins that specifically bind to the LRP5/6 co-receptors, preventing Wnt ligand binding and thereby inhibiting downstream β-catenin signaling. This inhibition plays crucial roles in:
DKK1 is significantly upregulated in Alzheimer's disease brains, particularly in regions vulnerable to neurodegeneration like the hippocampus and entorhinal cortex. Elevated DKK1 levels:
In Parkinson's disease, DKK1 expression is altered in the substantia nigra and may influence dopaminergic neuron survival through Wnt pathway modulation.
DKK1 is being investigated as a therapeutic target for:
The study of Dkk1 — Dickkopf Wnt Signaling Pathway Inhibitor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.